CHORDOMA

Clinical trials for CHORDOMA explained in plain language.

Never miss a new study

Get alerted when new CHORDOMA trials appear

Sign up with your email to follow new studies for CHORDOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 4 Completed 1

First test of new drug combo for rare bone cancer

Disease control Completed

This study tested whether adding an oral drug called nilotinib to standard radiation therapy was safe for people with high-risk chordoma, a rare type of bone cancer. The main goal was to find the highest safe dose of nilotinib when given alongside radiation. Researchers hoped the…

Matched conditions: CHORDOMA

Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Feb 23, 2026 14:56 UTC

CHORDOMA

Get alerted when new CHORDOMA trials appear

First test of new drug combo for rare bone cancer